IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.509
EU - Europa 7.859
AS - Asia 6.353
SA - Sud America 1.043
AF - Africa 138
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 26.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.300
PL - Polonia 3.263
CN - Cina 2.128
SG - Singapore 2.013
UA - Ucraina 1.056
IT - Italia 871
BR - Brasile 854
DE - Germania 773
HK - Hong Kong 630
VN - Vietnam 507
FI - Finlandia 422
GB - Regno Unito 378
FR - Francia 359
IN - India 329
RU - Federazione Russa 244
TR - Turchia 206
IE - Irlanda 183
BD - Bangladesh 157
CA - Canada 115
ID - Indonesia 67
AR - Argentina 61
MX - Messico 58
NL - Olanda 58
JP - Giappone 49
IQ - Iraq 48
SE - Svezia 45
BE - Belgio 44
ZA - Sudafrica 43
ES - Italia 37
KR - Corea 35
CZ - Repubblica Ceca 31
PK - Pakistan 28
AT - Austria 27
EC - Ecuador 27
CO - Colombia 25
UZ - Uzbekistan 23
VE - Venezuela 21
CL - Cile 18
KE - Kenya 18
MA - Marocco 18
IR - Iran 17
AU - Australia 16
EU - Europa 16
IL - Israele 16
NG - Nigeria 13
SA - Arabia Saudita 12
JO - Giordania 11
PE - Perù 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
AZ - Azerbaigian 9
UY - Uruguay 9
CH - Svizzera 8
ET - Etiopia 8
JM - Giamaica 8
LT - Lituania 8
OM - Oman 8
PH - Filippine 8
DZ - Algeria 7
BO - Bolivia 6
EG - Egitto 6
MU - Mauritius 6
AL - Albania 5
HN - Honduras 5
LV - Lettonia 5
NP - Nepal 5
RO - Romania 5
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
MD - Moldavia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
SV - El Salvador 3
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
Totale 26.917
Salva come PNG Salva come JPEG
Città #
Warsaw 3.257
Singapore 1.051
Fairfield 1.040
Ashburn 977
Woodbridge 812
Jacksonville 732
Hong Kong 624
Houston 622
Ann Arbor 493
Chandler 474
Cambridge 441
Beijing 440
San Jose 420
Seattle 413
Wilmington 386
The Dalles 341
Princeton 315
New York 306
Nanjing 298
Brescia 285
Helsinki 256
Los Angeles 251
Dearborn 206
Dallas 183
Dublin 182
Lauterbourg 171
Istanbul 165
Council Bluffs 142
Dong Ket 126
Ho Chi Minh City 117
Munich 111
Milan 104
Buffalo 101
Des Moines 101
Chicago 94
Nanchang 90
Pune 84
San Francisco 84
Hanoi 81
São Paulo 81
Shenyang 80
Moscow 74
Hebei 71
Shanghai 71
Jinan 69
Tianjin 69
Redondo Beach 68
Lancaster 65
Santa Clara 65
Changsha 62
Orem 56
London 55
San Diego 52
Jakarta 49
Phoenix 46
Brussels 41
Montreal 38
Chennai 36
Denver 36
Toronto 35
Turku 35
Brooklyn 34
Guangzhou 33
Kunming 32
Rome 32
Jiaxing 31
Hangzhou 30
Salt Lake City 30
Ningbo 29
Tokyo 29
Zhengzhou 29
Amsterdam 26
Rio de Janeiro 26
Nuremberg 25
Atlanta 23
Baghdad 22
Frankfurt am Main 22
Lanzhou 22
Taizhou 22
Tashkent 22
Verona 22
Brasília 21
Johannesburg 21
Manchester 20
Norwalk 20
Boardman 19
Boston 19
Brno 19
Mexico City 19
Stockholm 19
Belo Horizonte 18
Mumbai 18
Orange 18
Poplar 18
Porto Alegre 18
Tampa 18
Haikou 17
Nairobi 17
Paris 17
Augusta 16
Totale 18.523
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 374
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 365
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 331
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 328
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 328
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 322
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 319
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 317
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 313
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 313
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 306
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 303
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 298
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 292
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 287
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 278
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 277
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 270
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 264
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 263
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 263
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 258
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 242
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 219
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 218
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 210
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 208
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 205
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 204
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 202
The Role of Mast Cells in Stroke 201
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 199
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 199
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 198
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 197
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 197
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 192
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 191
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 190
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 189
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 182
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 182
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 177
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 177
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 175
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 174
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 172
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 172
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 170
Synapsin III alterations in Parkinson's disease 166
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 166
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 163
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 163
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 162
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 162
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 161
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 161
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 156
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 155
Cortical neurons induce the expression of glutamate receptors in primary myotubes 153
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 153
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 151
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 151
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 147
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 147
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 145
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 145
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 144
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 144
An in vitro method of diagnosing Parkinson's disease 144
Synapsin III Alteration in Parkinson's disease 143
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 141
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 140
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 140
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 140
Pharmacological basis for dopamine D-2 receptor diversity 139
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 139
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 139
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 139
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 138
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 138
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 138
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 137
Synapsin III Alteration in Parkinson's disease 137
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 136
From preclinical stroke models to humans: Polyphenols in the prevention and treatment of stroke 136
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 135
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 134
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 133
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 132
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 132
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 131
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 131
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 131
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 129
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 129
Raman Probes for in Situ Molecular Analyses of Peripheral Nerve Myelination 129
NF-kappaB dimer heterogeneity: a molecular determinant of neuron vulnerability in post ischemic brain damage 128
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 128
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 127
Totale 19.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 0 0 0 0 0 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20267.374 707 896 551 1.048 745 566 1.068 331 435 576 334 117
Totale 27.516